Fc-fucosylation of <i>Plasmodium falciparum</i> -specific IgG varies with antigen and immunization
BACKGROUND: IgG-mediated effector functions are modulated by the antibody Fc-region glycan composition, and the absence of core fucose is a strong modifier of NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC). Most plasma IgG is fully Fc-fucosylated, but antigens displayed on host-derived membranes can selectively induce Fc-afucosylated IgG. These antigens include alloantigens, enveloped virus surface proteins, and PfEMP1, a malaria parasite protein expressed on the surface of Plasmodium falciparum-infected erythrocytes (IEs). METHODS: We determined levels and Fc-fucosylation of IgG specific for several P. falciparum antigens in plasma from children naturally exposed to P. falciparum and from vaccinated adults. RESULTS: IgG specific for PfEMP1 (known to be exposed on the IE surface) and PfGARP, a putative IE surface antigen, were markedly Fc-afucosylated, whereas IgG specific for antigens on parasite membranes (merozoites, gametocytes/gametes, and sporozoites) were fully Fc-fucosylated in most of the children naturally exposed to P. falciparum studied here. Immunization of adults with recombinant proteins (MSP1, Pfs230, and CSP) also consistently induced fully Fc-fucosylated IgG. Children with Fc-afucosylated PfGARP-specific IgG had reduced risk of carrying P. falciparum parasites, independent of levels of PfGARP-specific IgG. CONCLUSIONS: These results reinforce the hypothesis that Fc-afucosylation of antigen-specific IgG requires exposure of the antigen on a host membrane (context) and is a function of antigen exposure. Host-specific factors appear to play a minor role in this context.
Authors
- Gestur Vidarsson (ORCID: https://orcid.org/0000-0001-5621-003X)
- Alfred B. Tiono (ORCID: https://orcid.org/0000-0002-5104-3946)
- Zakaria Seidu (ORCID: https://orcid.org/0000-0001-8017-2491)
- Richard Thomson-Luque (ORCID: https://orcid.org/0000-0001-8378-9497)
- Michael Theisen (ORCID: https://orcid.org/0000-0003-4412-1392)
- Mads Delbo Larsen (ORCID: https://orcid.org/0000-0002-1985-5901)
- Frederica Dedo Partey (ORCID: https://orcid.org/0000-0002-3977-1449)
- Michael Lanzer (ORCID: https://orcid.org/0000-0002-0220-6526)
- Michael F. Ofori (ORCID: https://orcid.org/0000-0003-2341-7514)
- Michael J. Blackman (ORCID: https://orcid.org/0000-0002-7442-3810)
- Maria Inês dos Santos (ORCID: https://orcid.org/0000-0001-5826-6782)
- Lars Hviid (ORCID: https://orcid.org/0000-0002-1698-4927)
- Mary Lopez-Perez
- Manfred Wuhrer (ORCID: https://orcid.org/0000-0002-0814-4995)
- Jonathan Kurtis
Institutions
- Statens Serum Institut (DK)
- University of Copenhagen (DK)
- University of Ghana (GH)
- Universidade de São Paulo (BR)
- Utrecht University (NL)
- Heidelberg University (DE)
- Brown University (US)
- Leiden University Medical Center (NL)
- The Francis Crick Institute (GB)
- University Hospital Heidelberg (DE)
- Rigshospitalet (DK)
- Sanquin (NL)
- Noguchi Memorial Institute for Medical Research (GH)
- Netherlands Metabolomics Centre (NL)
- Neovii Biotech (Germany) (DE)
- Institute of Biomedical Science (GB)
- Groupe de Recherche et d’Action sur le Foncier (BF)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2026-06-09
- DOI
- https://doi.org/10.1093/infdis/jiag296
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00